… uptake of many effective antiarrhythmic therapies in these patients remains the slowest. This
European Heart Rhythm Association (EHRA) consensus document focuses on the biology …

… Class IC antiarrhythmic agents should not be used in … Therapeutic monitoring of drugs with
a narrow therapeutic window (eg… Other clinical decision support systems alert prescribers who …

… There is still no consensus on the minimum duration that defines an episode of AF … or poor
tolerance under antiarrhythmic drug therapy or as a first-choice treatment in selected patients. …

… this document either do not lend themselves to clinical trials … recommendations are based
on consensus expert opinion. … need for clinical judgment and patient-specific decision-making. …

… That SDM is recommended increasingly in professional society heart rhythm management
guidelines and consensus documents has raised controversy in view of the limited evidence …

… When SND and/or AV block are present in the setting of a channelopathy or as the result
of antiarrhythmic medications needed for treatment of a channelopathy, the indications for …

… relapse of the arrhythmia, it may be useful the administration of antiarrhythmic drugs such
as quinidine, propafenone, flecainide, amiodarone, sotalol, ibutilide or verapamil (Table 7). …

… Participants would be more reluctant to start antiarrhythmic drug therapy in this patient (28% …
An EHRA consensus document on screening for AF explicitly states new wearable devices …

… It may involve a combination of therapeutic approaches including synchronized electrical
cardioversion, the administration of antiarrhythmic drugs, and the application of interventional …

… VA is accomplished through antiarrhythmic drugs (AADs) and … in mind during clinical
decision making, especially in the … evidence base for its routine use in clinical practice, it is often …